Perrigo (PRGO) Competitors $21.36 -0.39 (-1.79%) Closing price 03:59 PM EasternExtended Trading$21.53 +0.17 (+0.80%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PRGO vs. JAZZ, CORT, SUPN, PCRX, NKTR, OMER, ASMB, CPIX, LLY, and JNJShould you be buying Perrigo stock or one of its competitors? The main competitors of Perrigo include Jazz Pharmaceuticals (JAZZ), Corcept Therapeutics (CORT), Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX), Nektar Therapeutics (NKTR), Omeros (OMER), Assembly Biosciences (ASMB), Cumberland Pharmaceuticals (CPIX), Eli Lilly and Company (LLY), and Johnson & Johnson (JNJ). These companies are all part of the "pharmaceuticals" industry. Perrigo vs. Its Competitors Jazz Pharmaceuticals Corcept Therapeutics Supernus Pharmaceuticals Pacira BioSciences Nektar Therapeutics Omeros Assembly Biosciences Cumberland Pharmaceuticals Eli Lilly and Company Johnson & Johnson Perrigo (NYSE:PRGO) and Jazz Pharmaceuticals (NASDAQ:JAZZ) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment. Does the media prefer PRGO or JAZZ? In the previous week, Jazz Pharmaceuticals had 6 more articles in the media than Perrigo. MarketBeat recorded 19 mentions for Jazz Pharmaceuticals and 13 mentions for Perrigo. Perrigo's average media sentiment score of 1.55 beat Jazz Pharmaceuticals' score of 1.34 indicating that Perrigo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Perrigo 9 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Jazz Pharmaceuticals 16 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, PRGO or JAZZ? Jazz Pharmaceuticals has lower revenue, but higher earnings than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPerrigo$4.37B0.67-$171.80M-$0.58-36.83Jazz Pharmaceuticals$4.07B1.89$560.12M-$6.73-18.80 Which has more risk & volatility, PRGO or JAZZ? Perrigo has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Comparatively, Jazz Pharmaceuticals has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500. Do analysts rate PRGO or JAZZ? Perrigo currently has a consensus target price of $33.00, indicating a potential upside of 54.49%. Jazz Pharmaceuticals has a consensus target price of $178.67, indicating a potential upside of 41.19%. Given Perrigo's higher possible upside, research analysts clearly believe Perrigo is more favorable than Jazz Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perrigo 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40Jazz Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.88 Is PRGO or JAZZ more profitable? Perrigo has a net margin of -1.86% compared to Jazz Pharmaceuticals' net margin of -9.91%. Perrigo's return on equity of 9.09% beat Jazz Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Perrigo-1.86% 9.09% 3.96% Jazz Pharmaceuticals -9.91%5.02%1.73% Do insiders and institutionals believe in PRGO or JAZZ? 95.9% of Perrigo shares are owned by institutional investors. Comparatively, 89.1% of Jazz Pharmaceuticals shares are owned by institutional investors. 0.4% of Perrigo shares are owned by company insiders. Comparatively, 4.3% of Jazz Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryPerrigo beats Jazz Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Get Perrigo News Delivered to You Automatically Sign up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRGO vs. The Competition Export to ExcelMetricPerrigoMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$2.99B$10.84B$5.73B$21.51BDividend Yield5.33%1.89%5.90%3.50%P/E Ratio-36.8321.3875.8629.83Price / Sales0.6729.21528.7453.44Price / Cash4.3124.4737.1724.76Price / Book0.673.4312.794.53Net Income-$171.80M$212.47M$3.28B$998.53M7 Day Performance-4.22%-1.00%0.22%1.07%1 Month Performance-6.03%2.17%4.61%4.41%1 Year Performance-24.28%-10.93%68.33%14.45% Perrigo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRGOPerrigo4.8947 of 5 stars$21.36-1.8%$33.00+54.5%-21.6%$2.99B$4.37B-36.838,379Positive NewsJAZZJazz Pharmaceuticals4.5203 of 5 stars$129.85+0.3%$178.67+37.6%+15.1%$7.86B$4.07B-19.292,800Positive NewsCORTCorcept Therapeutics4.8329 of 5 stars$71.23+2.7%$134.50+88.8%+82.4%$7.31B$675.04M63.04300Positive NewsSUPNSupernus Pharmaceuticals2.5838 of 5 stars$45.82-0.4%$43.00-6.2%+41.4%$2.58B$661.82M39.84580Insider TradePCRXPacira BioSciences3.3713 of 5 stars$26.74+1.1%$30.83+15.3%+104.9%$1.19B$700.97M12.60720Positive NewsNKTRNektar Therapeutics4.1648 of 5 stars$44.33+10.3%$88.33+99.3%+149.4%$764.17M$98.43M-5.04220High Trading VolumeOMEROmeros3.9521 of 5 stars$4.21+1.0%$18.00+327.6%+3.8%$283.79MN/A-2.00210Positive NewsASMBAssembly Biosciences3.4403 of 5 stars$23.32-2.1%$41.33+77.2%+17.3%$182.71M$28.52M-4.18100Short Interest ↑Gap UpCPIXCumberland Pharmaceuticals0.6117 of 5 stars$3.31flatN/A+162.0%$49.52M$37.87M-15.0580Positive NewsLLYEli Lilly and Company4.9979 of 5 stars$738.58+1.6%$950.17+28.6%-19.0%$688.27B$45.04B48.2747,000Trending NewsAnalyst ForecastJNJJohnson & Johnson4.683 of 5 stars$178.30-0.1%$176.29-1.1%+7.2%$429.72B$88.82B19.07138,100Trending NewsAnalyst Upgrade Related Companies and Tools Related Companies Jazz Pharmaceuticals Competitors Corcept Therapeutics Competitors Supernus Pharmaceuticals Competitors Pacira BioSciences Competitors Nektar Therapeutics Competitors Omeros Competitors Assembly Biosciences Competitors Cumberland Pharmaceuticals Competitors Eli Lilly and Company Competitors Johnson & Johnson Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PRGO) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perrigo Company plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Perrigo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRGO Stock Alerts